News Conference News ACC 2025 Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT Caitlin E. Cox March 29, 2025
News Conference News SCAI 2024 Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows L.A. McKeown May 06, 2024
News Conference News ISET 2024 AI in Pulmonary Embolism: ‘Transformative’ for Patient Care Caitlin E. Cox January 30, 2024
News Conference News ISET 2024 Venous Stents: How to Choose Among the Wealth of Options Caitlin E. Cox January 26, 2024
News Conference News TCT 2022 Dedicated Catheter for Acute PE Shows Promise in IDE Trial L.A. McKeown September 17, 2022
News Conference News ESC 2022 DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark L.A. McKeown August 30, 2022
News Conference News AXIOMATIC-TKR: Milvexian Promising for VTE Prevention L.A. McKeown November 15, 2021
News Conference News TCT 2020 Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19 Michael O'Riordan October 14, 2020
News Conference News ISET 2019 Vici Venous Stent Shows Good Primary Patency, Few MAE by 12 Months: VIRTUS Caitlin E. Cox February 08, 2019
News Conference News ESC 2018 MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis Todd Neale August 26, 2018
News Conference News ESC 2016 Simplified VTE Protocol Rules Out Pulmonary Embolism, Reduces Use of CT Imaging: YEARS Study Michael O'Riordan September 02, 2016